Barro, C., A. A. M. Affonso, A. Waquar, N. Aragao, A. Bakheet, K. Cajiao, A. B. C. Souza, L. A. Q. Díaz, C. M. Fowler, R. Herrera, L. A. N. Huapaya, K. Kornienko, A. M. V. Magalhães, T. d. O. Menezes, M.-A. Mordojovich, R. Nosé, H. Pan, K. S. Persivale, C. Poveda, C. Ramos, M. A. Rodrigues, J. M. V. Ruiz, R. Soares, and X. DangHan. “The INCA Trial: A Multicenter, Randomized, Phase II, Open-Label Clinical Trial to Evaluate the Combination Therapy With Ipilimumab Plus Nivolumab Versus Chemotherapy (Pemetrexate-Cisplatin) in Patients With Advanced Non-Squamous NSCLC Naive to Treatment”. Principles and Practice of Clinical Research, vol. 4, no. 1, July 2018, pp. 6-13,